Skip to main content

Table 1 Demographic, pathological, and clinical characteristics of enrolled patients with pancreatic adenocarcinoma

From: Diagnostic and prognostic significance of tissue lncRNA HOTAIR and hexokinase 2 mRNA expression in patients with pancreatic ductal adenocarcinoma

Characteristic

Value (%)

Patient number

25 (100%)

Gender (males/females)

18 (72%)/7 (28%)

Age range (years)

36–76

Age, mean (± standard deviation)

57.16 ± 10.41

HBs–Ag positive cases

1 (4%)

Tumor location

 Head of the pancreas

21 (84%)

 Body and tail of the pancreas

4 (16%)

 Tumor size (greatest dimension, cm)

2.5–8.0

 Superior mesenteric vein encasement

20 (80%)

Pathological stage

 T2

15 (60%)

 T3

10 (40%)

Nodal metastasis

 N0

3 (12%)

 N1

10 (40%)

 N2

12 (48%)

 Lympho-vascular invasion

11 (44%)

 Perineural invasion

24 (96%)

 Tumor recurrence

6 (24%)

 Post-surgical survival (months)

2.0–36.0

 Mean survival (± SD, months)

11.24 ± 8.57

 One-year survival

13 (52%)

  1. T2 tumor pathological stage 2 (greater than 2 cm but less than 4 cm) on gross examination. T3 tumor pathological stage 3 (greater than 4 cm but less than 5 cm) on gross examination. N0 No nodal involvement. N1 nodal metastasis, stage 1. N2: Nodal metastasis, stage 2